Principal Financial Group Inc. Decreases Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Principal Financial Group Inc. reduced its position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 2.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,606,511 shares of the company's stock after selling 46,254 shares during the quarter. Principal Financial Group Inc. owned 1.19% of AdaptHealth worth $17,415,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of AHCO. Reinhart Partners LLC. lifted its holdings in AdaptHealth by 15.5% during the 1st quarter. Reinhart Partners LLC. now owns 7,236,262 shares of the company's stock valued at $78,441,000 after buying an additional 969,408 shares in the last quarter. Segall Bryant & Hamill LLC raised its stake in shares of AdaptHealth by 29.8% during the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock valued at $45,734,000 after acquiring an additional 1,102,173 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of AdaptHealth by 17.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company's stock valued at $32,174,000 after purchasing an additional 505,180 shares during the period. Geode Capital Management LLC grew its stake in AdaptHealth by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 2,467,769 shares of the company's stock worth $23,499,000 after purchasing an additional 16,596 shares in the last quarter. Finally, Kennedy Capital Management LLC increased its holdings in AdaptHealth by 6.0% during the 4th quarter. Kennedy Capital Management LLC now owns 1,767,310 shares of the company's stock worth $16,825,000 after purchasing an additional 99,326 shares during the period. 82.67% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Royal Bank Of Canada dropped their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research report on Thursday, May 8th. Truist Financial lowered their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research note on Monday, May 12th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, AdaptHealth currently has a consensus rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Stock Down 0.5%

Shares of NASDAQ:AHCO traded down $0.05 on Monday, reaching $9.17. The company had a trading volume of 793,434 shares, compared to its average volume of 1,330,594. The firm has a market capitalization of $1.24 billion, a PE ratio of 16.09, a PEG ratio of 1.07 and a beta of 1.63. The company has a current ratio of 1.29, a quick ratio of 1.07 and a debt-to-equity ratio of 1.25. AdaptHealth Corp. has a 52-week low of $7.11 and a 52-week high of $11.90. The firm's 50 day simple moving average is $8.94 and its 200-day simple moving average is $9.41.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.